Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,093-1,104 of 6,115
Drug study icon
Recruitment unclearEUCTR 2018-001884-21

A randomised, placebo-controlled, double-blind trial of the antidepressant efficacy of a novel CNS-penetrant P2X7 receptor antagonist, JNJ-54175446, in people with major depressive disorder, an inc...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
Cambridgeshire and Peterborough NHS Foundation Trust and University of Cambridge
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2008-008918-39

BRAIN DERIVED NEUROTROPHIC FACTOR AND MAJOR DEPRESSIVE DISORDER TREATMENT: CLINICAL PSYCHOLOGICAL AND PSYCHOPHARMACOTHERAPIC EVALUATIONS

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Italy
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Italy
Sponsor
AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2008-005695-27

Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
Netherlands
Sponsor
Eli Lilly Nederland
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2019-001683-29

Double-Blind, Placebo-Controlled, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-61393215 as Adjunctive Treatment in Adults with Major Depressive Disorder with Anxio...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom
Sponsor
Janssen-Cilag International NV
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2017-003288-36

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression (P-TRD)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study is directly about Depression.

DepressionDrug
Countries
United Kingdom, Czechia, Denmark, ...
Sponsor
COMPASS Pathways, Ltd
Condition
Depression
Behavioral study icon
RecruitingNCT07007234

Sedentary Behavior and Depressive Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including São Paulo
Why is this study shown?

This study is directly about Depression.

Depression, AnxietyBehavioralOver 18 Years
Countries
Brazil
Sponsor
University of Sao Paulo General Hospital
Condition
Depression, Anxiety
Device study icon
RecruitingNCT06294184

TDCS Interventions for Subthreshold Depressive Symptoms in Young Individuals.

This summary needs review. Please check the official study record and contact the research team for details.

In Guangzhou
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 25 Years
Countries
China
Sponsor
Guangzhou Psychiatric Hospital
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.